Oxford Biodynamics Debt 2024

Oxford Biodynamics Aktienanalyse

What does Oxford Biodynamics do?

Oxford Biodynamics PLC is a company specialized in the development and application of epigenetic technologies. It was founded in 2007 in Oxford, United Kingdom and has since then had an impressive track record in researching and developing new methods for the detection and treatment of diseases. The business model of Oxford Biodynamics is to utilize its proprietary technology platform, EpiSwitch®, to offer validation and screening services to customers in the pharmaceutical and biotech industries. Oxford Biodynamics' technology platform utilizes epigenetic information to diagnose and predict diseases. The company also uses its technology to identify biomarkers that provide unique insights into the biological processes associated with specific diseases. Oxford Biodynamics operates in three main areas: diagnostics, research and development, and nanoparticle technology. In the diagnostics field, the company offers blood tests for early detection of breast cancer and other types of cancer. The tests utilize a combination of epigenetic signatures and artificial intelligence to deliver results. Oxford Biodynamics is also developing a test to aid in the diagnosis of neurodegenerative diseases such as Parkinson's and Alzheimer's. In the research and development field, Oxford Biodynamics collaborates closely with pharmaceutical and biotech companies to identify epigenetic signatures specific to certain diseases. The company has already worked with major pharmaceutical companies to test the effectiveness of drugs in treating lung cancer and breast cancer. Oxford Biodynamics has also started a collaboration with the John Radcliffe Hospital in Oxford to develop new epigenetics-based methods for predicting premature births. In the nanoparticle technology field, the company utilizes its expertise in epigenetics to develop new technologies that enhance drug delivery and increase the therapeutic effects of medications. The company is currently developing a new type of nanoparticles specifically designed to target cancer cells. These nanoparticles are able to selectively concentrate on cancer cells and directly enter the targeted tissue, minimizing unwanted side effects and maximizing effectiveness. Overall, Oxford Biodynamics is a leading company in epigenetics research and technology development. The company has already made significant advancements in developing new diagnostic and therapeutic methods for various diseases and is constantly working to improve its technologies and expand its product range. The future of the company looks very promising as epigenetics becomes increasingly important in medical research and diagnostics, and Oxford Biodynamics is one of the leading companies in this field. Oxford Biodynamics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Oxford Biodynamics's Debt Structure

Oxford Biodynamics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Oxford Biodynamics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Oxford Biodynamics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Oxford Biodynamics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Oxford Biodynamics stock

What is the debt of Oxford Biodynamics this year?

Oxford Biodynamics has a debt level of 1.19 GBP this year.

What was the debt of Oxford Biodynamics compared to the previous year?

The debt of Oxford Biodynamics has increased by -76.97% compared to the previous year dropped.

What are the consequences of high debt for investors in Oxford Biodynamics?

High debt can pose a risk for investors of Oxford Biodynamics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Oxford Biodynamics?

Low debt means that Oxford Biodynamics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Oxford Biodynamics affect the company?

An increase in debt of Oxford Biodynamics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Oxford Biodynamics affect the company?

A reduction in debt of Oxford Biodynamics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Oxford Biodynamics?

Some factors that can influence the debt of Oxford Biodynamics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Oxford Biodynamics so important for investors?

The debts of Oxford Biodynamics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Oxford Biodynamics take to change the debt?

To change the debt, Oxford Biodynamics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Oxford Biodynamics pay?

Over the past 12 months, Oxford Biodynamics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oxford Biodynamics is expected to pay a dividend of 0 GBP.

What is the dividend yield of Oxford Biodynamics?

The current dividend yield of Oxford Biodynamics is .

When does Oxford Biodynamics pay dividends?

Oxford Biodynamics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oxford Biodynamics?

Oxford Biodynamics paid dividends every year for the past 0 years.

What is the dividend of Oxford Biodynamics?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oxford Biodynamics located?

Oxford Biodynamics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oxford Biodynamics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oxford Biodynamics from 9/28/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 9/28/2024.

When did Oxford Biodynamics pay the last dividend?

The last dividend was paid out on 9/28/2024.

What was the dividend of Oxford Biodynamics in the year 2023?

In the year 2023, Oxford Biodynamics distributed 0 GBP as dividends.

In which currency does Oxford Biodynamics pay out the dividend?

The dividends of Oxford Biodynamics are distributed in GBP.